Park Jaeho, Sempionatto Juliane R, Kim Jayoung, Jeong Yongrok, Gu Jimin, Wang Joseph, Park Inkyu
Department of Mechanical Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, South Korea.
Department of NanoEngineering, University of California, San Diego, La Jolla, California 92093, United States.
ACS Sens. 2020 May 22;5(5):1363-1373. doi: 10.1021/acssensors.0c00078. Epub 2020 Feb 27.
In vivo sensing of various physical/chemical parameters is gaining increased attention for early prediction and management of various diseases. However, there are major limitations on the fabrication method of multiparameter needle-based in vivo sensing devices, particularly concerning the uniformity between sensors. To address these challenges, we developed a microscale biosensor array for the measurement of electrical conductivity, pH, glucose, and lactate concentrations on a flexible polymeric polyimide platform with electrodeposited electrochemically active layers. The biosensor array was then transferred to a medical needle toward multiparametric in vivo sensing. The flexibility of the sensor platform allowed an easy integration to the curved surface (φ = 1.2 mm) of the needle. Furthermore, the electrodeposition process was used to localize various active materials for corresponding electrochemical sensors on the microscale electrodes with a high precision (patterning area = 150 μm × 2 mm). The biosensor array-modified needle was aimed to discriminate cancer from normal tissues by providing real-time discrimination of glucose, lactate concentration, pH, and electrical conductivity changes associated with the cancer-specific metabolic processes. The sensor performance was thus evaluated using solution samples, covering the physiological concentrations for cancer discrimination. Finally, the possibility of in vivo electrochemical biosensing during needle insertion was confirmed by utilizing the needle in a hydrogel phantom that mimicked the normal and cancer microenvironments.
对各种物理/化学参数进行体内传感在各种疾病的早期预测和管理方面越来越受到关注。然而,基于针的多参数体内传感装置的制造方法存在重大限制,特别是在传感器之间的均匀性方面。为应对这些挑战,我们在具有电沉积电化学活性层的柔性聚合物聚酰亚胺平台上开发了一种用于测量电导率、pH值、葡萄糖和乳酸浓度的微尺度生物传感器阵列。然后将该生物传感器阵列转移到医用针上,用于多参数体内传感。传感器平台的灵活性使其能够轻松集成到针的弯曲表面(φ = 1.2毫米)。此外,电沉积过程用于在微尺度电极上高精度地定位用于相应电化学传感器的各种活性材料(图案化面积 = 150μm×2mm)。生物传感器阵列修饰的针旨在通过实时区分与癌症特异性代谢过程相关的葡萄糖、乳酸浓度、pH值和电导率变化来区分癌症组织和正常组织。因此,使用溶液样品评估了传感器性能,涵盖了用于癌症区分的生理浓度。最后,通过在模拟正常和癌症微环境的水凝胶模型中使用该针,证实了在针插入过程中进行体内电化学生物传感的可能性。